Rapamycin treatment increases survival, autophagy biomarkers and expression of the anti‐aging klotho protein in elderly mice
Kitti Szőke(University of Debrecen), István Lekli(University of Debrecen), Zoltán Papp(University of Debrecen), Árpád Tósaki(University of Debrecen), Alexandra Gyöngyösi(University of Debrecen), Attila Czompa(University of Debrecen), Beáta Bódi(University of Debrecen), D. Haines(Oxford Biotherapeutics (United Kingdom)), Zoltán Hendrik(University of Debrecen)
Cited by 17
Related Papers
Current State of Knowledge on Aetiology, Diagnosis, Management, and Therapy of Peripartum Cardiomyopathy: A Position Statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy
|European Journal of Heart Failure|2010|1.1k
Levosimendan: Molecular mechanisms and clinical implications
|International Journal of Cardiology|2011|313
The continuous heart failure spectrum: moving beyond an ejection fraction classification
|European Heart Journal|2019|258
Treatments targeting inotropy
|European Heart Journal|2018|227
Levosimendan Efficacy and Safety: 20 Years of SIMDAX in Clinical Use
|Journal of Cardiovascular Pharmacology|2020|111